$-0.03 EPS Expected for Bovie Medical (BVX); 13 Analysts Covering Anheuser Busch Inbev NV (ADR) (BUD)

July 28, 2017 - By test

Among 21 analysts covering Anheuser-Busch InBev (NYSE:BUD), 13 have Buy rating, 1 Sell and 7 Hold. Therefore 62% are positive. Anheuser-Busch InBev has $157 highest and $100 lowest target. $122.59’s average target is -0.20% below currents $122.84 stock price. Anheuser-Busch InBev had 36 analyst reports since July 21, 2015 according to SRatingsIntel. The stock of Anheuser Busch Inbev NV (ADR) (NYSE:BUD) earned “Hold” rating by Susquehanna on Thursday, July 27. The firm has “Outperform” rating by RBC Capital Markets given on Tuesday, September 8. The firm has “Buy” rating by Sterne Agee CRT given on Thursday, September 17. Goldman Sachs maintained Anheuser Busch Inbev NV (ADR) (NYSE:BUD) on Monday, July 10 with “Buy” rating. The stock of Anheuser Busch Inbev NV (ADR) (NYSE:BUD) earned “Hold” rating by ING Group on Wednesday, August 26. HSBC downgraded the shares of BUD in report on Monday, November 14 to “Hold” rating. The stock has “Underperform” rating by RBC Capital Markets on Monday, October 10. The rating was downgraded by Bank of America to “Neutral” on Thursday, March 2. Credit Agricole upgraded the stock to “Outperform” rating in Monday, November 2 report. The stock of Anheuser Busch Inbev NV (ADR) (NYSE:BUD) has “Hold” rating given on Thursday, October 20 by Societe Generale. See Anheuser Busch Inbev NV (ADR) (NYSE:BUD) latest ratings:

27/07/2017 Broker: Susquehanna Rating: Hold New Target: $111.0000 Maintain
10/07/2017 Broker: Goldman Sachs Rating: Buy Maintain
27/06/2017 Broker: Jefferies Rating: Buy New Target: $132.0000 Maintain
23/06/2017 Broker: Stifel Nicolaus Rating: Buy Old Target: $134.00 New Target: $140.00 Target Up
05/05/2017 Broker: Susquehanna Rating: Hold New Target: $103.00 Maintain
02/03/2017 Broker: Bank of America Old Rating: Buy New Rating: Neutral Old Target: $120.00 New Target: $115.00 Downgrade

Analysts expect Bovie Medical Corporation (NYSEMKT:BVX) to report $-0.03 EPS on August, 2 after the close.They anticipate $0.01 EPS change or 50.00% from last quarter’s $-0.02 EPS. After having $-0.06 EPS previously, Bovie Medical Corporation’s analysts see -50.00% EPS growth. The stock increased 2.45% or $0.06 on July 27, reaching $2.51. About shares traded. Bovie Medical Corporation (NYSEMKT:BVX) has risen 28.74% since July 28, 2016 and is uptrending. It has outperformed by 12.04% the S&P500.

The stock increased 6.16% or $7.13 during the last trading session, reaching $122.84. About 3,300 shares traded. Anheuser Busch Inbev NV (ADR) (NYSE:BUD) has declined 3.55% since July 28, 2016 and is downtrending. It has underperformed by 20.25% the S&P500.

Anheuser Busch Inbev NV is a Belgium firm engaged in the brewers industry. The company has market cap of $207.74 billion. The Firm owns a portfolio of over 200 beer brands. It has a 102.71 P/E ratio. The Company’s brand portfolio includes global brands, such as Budweiser, Corona and Stella Artois; international brands, including Beck’s, Leffe and Hoegaarden, and local champions, such as Bud Light, Skol, Brahma, Antarctica, Quilmes, Victoria, Modelo Especial, Michelob Ultra, Harbin, Sedrin, Klinskoye, Sibirskaya Korona, Chernigivske, Cass and Jupiler.

Investors sentiment decreased to 1 in Q4 2016. Its down 0.02, from 1.02 in 2016Q3. It is negative, as 66 investors sold Anheuser Busch Inbev NV (ADR) shares while 144 reduced holdings. 61 funds opened positions while 150 raised stakes. 78.58 million shares or 13.08% less from 90.41 million shares in 2016Q3 were reported. Bollard Ltd Liability Corp owns 116 shares. Tcw Gru holds 0.02% in Anheuser Busch Inbev NV (ADR) (NYSE:BUD) or 29,362 shares. Pittenger Anderson reported 0.18% of its portfolio in Anheuser Busch Inbev NV (ADR) (NYSE:BUD). The North Carolina-based First Citizens Retail Bank & has invested 0.02% in Anheuser Busch Inbev NV (ADR) (NYSE:BUD). Spot Trading Limited Liability Corp holds 14,115 shares or 0.03% of its portfolio. Bnp Paribas Arbitrage Sa stated it has 0.01% in Anheuser Busch Inbev NV (ADR) (NYSE:BUD). Allen Investment Limited Liability owns 122,634 shares or 0.89% of their US portfolio. 5,756 were accumulated by Quantitative Systematic Strategies Ltd Co. Panagora Asset holds 25,939 shares. Leavell Invest Management Inc reported 17,243 shares. Mawer Mgmt Ltd owns 82,054 shares for 0.09% of their portfolio. Orca Invest Lc stated it has 2.09% of its portfolio in Anheuser Busch Inbev NV (ADR) (NYSE:BUD). Capital Advisers Ltd Liability reported 0.04% stake. Fil invested in 649,985 shares or 0.2% of the stock. Guyasuta Investment Advsr owns 11,590 shares for 0.16% of their portfolio.

Bovie Medical Corporation is an energy medical device company. The company has market cap of $77.46 million. The Firm is engaged in the design, development and manufacturing of electrosurgical equipment by producing equipment for medical device manufacturers through original equipment manufacturing (OEM) agreements, as well as start-up companies. It currently has negative earnings. It operates through three divisions: Core, OEM and J-Plasma.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Twitter Auto Publish Powered By : XYZScripts.com